Kehmann L, Berres ML, Gonzalez-Carmona M, Modest DP, et al. Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC). BMC Cancer 2023;23:470.
PMID: 37217885